Le Lézard
Classified in: Health
Subjects: PDT, ESG

Doximity Underscores Commitment to Corporate Social Responsibility with Launch of ESG Website


Company's mission to support clinicians aligned with ESG commitments and impact

SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced the launch of its Environmental, Social and Governance (ESG) website. Doximity recently marked its first anniversary as a public company, and is committed to creating long-term value for all stakeholders by operating responsibly, sustainably and ethically. The launch of the company's ESG website highlights this commitment and will help establish the transparency and foundational framework to continue making a positive impact on the U.S. healthcare system and society. 

"At Doximity, it's our mission to help physicians be more efficient, so they can provide better care for their patients," said Jeff Tangney, co-founder and CEO of Doximity. "Our new ESG website highlights our broader commitments to building a healthier world."

Doximity's ESG website highlights the company's impact and priorities across a number of areas that align with the United Nations Sustainable Development Goals, including:

For more information, visit Doximity's ESG website at doximity.com/ESG.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information visit Doximity.com.

For investors:
Perry Gold
[email protected]

For media:
Amanda Cox
[email protected]

SOURCE Doximity, Inc.


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: